PD—L1和P63在弥漫大B细胞淋巴瘤中的表达及临床意义(4)
[9] Mondino A，Jenkins M K.Surface proteins involved in T cell costimulation[J].J Leukoc Biol，1994，55(6)：805-815.
[10] Zou W，Chen L.Inhibitory B7-family molecules in the tumour microenvironment[J].Nat Rev Immunol，2008，8(6)：467-477.
[11] Konishi J，Yamazaki K，Azuma M，et al.B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression[J].Clin Cancer Res，2004，10(15)：5094-5100.
[12]李建虎.B7-H1/PD-1在弥漫大B细胞淋巴瘤中的表达及预后相关研究[D].杭州：浙江大学，2015.
[13] Wu C，Zhu Y，Jiang J，et al.Immunohistochemical localization of programmed death-1 ligand-1(PD-L1) in gastric carcinoma and its clinical significance[J].Acta Histochemica，2006，108(1)：19-24.
[14] Yang A，Kaghad M，Wang Y，et al.p63，a p53 homolog at 3q27-29，encodes multiple products with transactivating，death-inducing，and dominant-negative activities[J].Mol Cell，1998，2(3)：305-316.
[15]左学兰，周颖，周新，等.存活蛋白和P63蛋白在B細胞非霍奇金淋巴瘤组织中的表达及其对细胞凋亡和增殖的作用[J].中国实验血液学杂志，2007，15(1)：99-102.
[16] Hedvat C V，Teruya-Feldstein J，Puig P，et al.Expression of p63 in diffuse large B-cell lymphoma[J].Appl Immunohistochem Mol Morphol，2005，13(3)：237-242.
[17] Fukushima N，Satoh T，Sueoka N，et al.Clinico-pathological characteristics of p63 expression in B-cell lymphoma[J].Cancer Sci，2006，97(10)：1050-1055.
[18] Kataoka K，Shiraishi Y，Takeda Y，et al.Aberrant PD-L1 expression through 3’-UTR disruption in multiple cancers[J].Nature，2016，534(7607)：402-406.
[19] Georgiou K，Chen L，Berglund M，et al.Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas[J].Blood，2016，127(24)：3026.
[20] Scott D W，Mungall K L，Benneriah S，et al.TBL1XR1/TP63：a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma[J].Blood，2012，119(21)：4949-4952.
[21] Dong L，Lv H，Li W，et al.Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells[J].Oncotarget，2016，7(22)：33350-33362.
[22] Cam M，Bid H K，Xiao L，et al.p53/TAp63 and AKT Regulate Mammalian Target of Rapamycin Complex 1(mTORC1) Signaling through Two Independent Parallel Pathways in the Presence of DNA Damage[J].J Biol Chem，2014，289(7)：4083-4094., http://www.100md.com(张长忠 冯瑶 郑绘霞)
[10] Zou W，Chen L.Inhibitory B7-family molecules in the tumour microenvironment[J].Nat Rev Immunol，2008，8(6)：467-477.
[11] Konishi J，Yamazaki K，Azuma M，et al.B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression[J].Clin Cancer Res，2004，10(15)：5094-5100.
[12]李建虎.B7-H1/PD-1在弥漫大B细胞淋巴瘤中的表达及预后相关研究[D].杭州：浙江大学，2015.
[13] Wu C，Zhu Y，Jiang J，et al.Immunohistochemical localization of programmed death-1 ligand-1(PD-L1) in gastric carcinoma and its clinical significance[J].Acta Histochemica，2006，108(1)：19-24.
[14] Yang A，Kaghad M，Wang Y，et al.p63，a p53 homolog at 3q27-29，encodes multiple products with transactivating，death-inducing，and dominant-negative activities[J].Mol Cell，1998，2(3)：305-316.
[15]左学兰，周颖，周新，等.存活蛋白和P63蛋白在B細胞非霍奇金淋巴瘤组织中的表达及其对细胞凋亡和增殖的作用[J].中国实验血液学杂志，2007，15(1)：99-102.
[16] Hedvat C V，Teruya-Feldstein J，Puig P，et al.Expression of p63 in diffuse large B-cell lymphoma[J].Appl Immunohistochem Mol Morphol，2005，13(3)：237-242.
[17] Fukushima N，Satoh T，Sueoka N，et al.Clinico-pathological characteristics of p63 expression in B-cell lymphoma[J].Cancer Sci，2006，97(10)：1050-1055.
[18] Kataoka K，Shiraishi Y，Takeda Y，et al.Aberrant PD-L1 expression through 3’-UTR disruption in multiple cancers[J].Nature，2016，534(7607)：402-406.
[19] Georgiou K，Chen L，Berglund M，et al.Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas[J].Blood，2016，127(24)：3026.
[20] Scott D W，Mungall K L，Benneriah S，et al.TBL1XR1/TP63：a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma[J].Blood，2012，119(21)：4949-4952.
[21] Dong L，Lv H，Li W，et al.Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells[J].Oncotarget，2016，7(22)：33350-33362.
[22] Cam M，Bid H K，Xiao L，et al.p53/TAp63 and AKT Regulate Mammalian Target of Rapamycin Complex 1(mTORC1) Signaling through Two Independent Parallel Pathways in the Presence of DNA Damage[J].J Biol Chem，2014，289(7)：4083-4094., http://www.100md.com(张长忠 冯瑶 郑绘霞)
参见：首页 > 医疗版 > 疾病专题 > 血液内科 > 淋巴瘤